Evidence map›Paper›PMID 30739294›Full record

ArticleEnvironmental science and pollution research international2019

Ameliorative effect of zinc oxide nanoparticles against potassium bromate-mediated toxicity in Swiss albino rats.

Iftekhar Hassan, Fohad Mabood Husain, Rais Ahmad Khan, Hossam Ebaid, Jameel Al-Tamimi, Ibrahim M Alhazza, Shazia Aman, Khalid Elfaki Ibrahim

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Aroma Profile and Biological Effects ofMolecules (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Dose-response analysis of potassium bromate-induced toxicity in Allium cepa L. meristematic cells.Environmental science and pollution research international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Iftekhar HassanDepartment of Zoology, College of Science, King Saud University, Building 05, Riyadh, 11451, Saudi Arabia. iftekharhassan2002@gmail.com.ORCID http://orcid.org/0000-0001-6993-9954
Fohad Mabood HusainDepartment of Food Science and Nutrition, College of Food and Agriculture, King Saud University, Riyadh, 11451, Saudi Arabia.
Rais Ahmad KhanDepartment of Chemistry, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Hossam EbaidDepartment of Zoology, College of Science, King Saud University, Building 05, Riyadh, 11451, Saudi Arabia.
Jameel Al-TamimiDepartment of Zoology, College of Science, King Saud University, Building 05, Riyadh, 11451, Saudi Arabia.
Ibrahim M AlhazzaDepartment of Zoology, College of Science, King Saud University, Building 05, Riyadh, 11451, Saudi Arabia.
Shazia AmanDepartment of Biochemistry, J N Medical College and Hospital, Aligarh Muslim University, Aligarh, 202002, India.
Khalid Elfaki IbrahimDepartment of Zoology, College of Science, King Saud University, Building 05, Riyadh, 11451, Saudi Arabia.
King Saud University · SAAligarh Muslim University · IN

Funding

King Abdulaziz City for Science and Technology KACST Project Number MS-67?36
6 · The paper itself

Abstract

Potassium bromate (PB) is a commonly used food additive, a prominent water disinfection by-product, and a class IIB carcinogen. It exerts a various degree of toxicity depending on its dose and exposure duration consumed with food and water in the living organisms. The present investigation aims to demonstrate the protective efficacy of zinc oxide nanoparticles (ZnO NPs) derived from Ochradenus arabicus (OA) leaf extract by green technology in PB-challenged Swiss albino rats. The rodents were randomly distributed, under the lab-standardized treatment strategy, into the following six treatment groups: control (group I), PB alone (group II), ZnO alone (group III), ZnO NP alone (group IV), PB + ZnO (group V), and PB + ZnO NPs (group VI). The rats were sacrificed after completion of the treatment, and their blood and liver samples were collected for further analysis. Group II showed extensive toxic effects with altered liver function markers (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, lactate dehydrogenase, gamma-glutamyl transferase, glutathione-S-transferase, and thioredoxin reductase) and compromised redox status (SOD, CAT, GR, GPx, GSH, MDA, and total carbonyl content). The histopathological analysis and comet assay further supported the biochemical results of the same group. Besides, group III also showed moderate toxicity evidenced by an alteration in most of the studied parameters while group IV demonstrated mild toxicity after biochemical analysis indicating the excellent biocompatibility of the NPs. However, group VI exhibited attenuation of the PB-induced toxic insults to a significant level as compared to group II, whereas group V failed to show similar improvement in the studied parameters. All these findings entail that the ZnO NPs prepared by green synthesis have significant ameliorative property against PB-induced toxicity in vivo. Moreover, administration of the NPs improved the overall health of the treated animals profoundly. Hence, these NPs have significant therapeutic potential against the toxic effects of PB and similar compounds in vivo, and they are suitable to be used at the clinical and industrial levels.

Indexed as

Alanine TransaminaseAnimalsAspartate AminotransferasesBiomarkersBromatesCarcinogensMaleNanoparticlesOxidation-ReductionOxidative StressProtective AgentsRatsZinc OxideAlanine TransaminaseAspartate AminotransferasesBiomarkersBromatesCarcinogenspotassium bromateProtective AgentsZinc OxideIn vivoNanoparticlesOxidative stressPotassium bromateToxicityZinc oxide

Identifiers

PMID30739294
OpenAlexW2912474054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.